Cantarona, Rolando Y.

HRN: 27-17-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/02/2025
06/08/2025
IV
500mg
Q24H
HAP
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines